01 1Shandong Anhong Pharmaceutical
01 1ABEMACICLIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-23
Pay. Date : 2024-08-27
DMF Number : 40315
Submission : 2024-08-30
Status : Active
Type : II
20
Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ABEMACICLIB, with a corresponding US DMF Number 40315.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 23, 2024, and payment made on August 27, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
